Is Exelixis, Inc. overvalued?

Exelixis, Inc. (EXEL) looks undervalued — trading about 45% below its fair value.

Undervalued

Price

$50.61

Fair value

$73.17

Current P/E

15.2

Normal P/E

21.9

Market cap

$12.72B

Dividend yield

0.0%

Return on equity

42.5%

Sector

Healthcare

Fair value compares EXEL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks